Raymond James Financial’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,033
Closed -$89.6K 5036
2025
Q2
$89.6K Buy
+9,033
New +$88.4K ﹤0.01% 4928

Other funds holding ANGO

Raymond James Financial's ANGO Position: Q3 2025 in Review

Raymond James Financial sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 9,033 shares — an estimated $89.6K sold.

Raymond James Financial first reported a position in ANGO in Q2 2025 and held it in 1 quarter. The position peaked at $89.6K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Raymond James Financial reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 9,033 AngioDynamics shares in Q3 2025, an estimated $89.6K.
  • Raymond James Financial first reported a position in AngioDynamics in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's AngioDynamics position peaked at $89.6K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.